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ABSTRACT
Di-isopropylfluorophosphate (DFP) labeled with phosphorus-32 was applied to fragments of
the diaphragm and sternomastoid muscles of the mouse, in conditions in which it saturated
all available sites at the motor endplates . After adequate washing and exchange with un-
labeled DFP, single endplates were obtained by microdissection and their radioactivity was
found by beta track radioautography. The number of sites phosphorylated by DFP 32P per
endplate was relatively constant for each muscle : in the sternomastoid, about 9 X 107 sites
per endplate, in the diaphragm, about 3 X 10 7. Reaction with DFP3"P was abolished by
prior treatment with unlabeled DFP. Labeling was unaffected by prior fixation in form-
aldehyde, but was inversely proportional to the time of incubation in the Koelle staining
medium, when this preceded labeling . The contribution of acetylcholinesterase (AChase) to
this total number of DFP-reactive sites was determined by three methods . The first involved
reactivation of the phosphorylated AChase by pyridine-2-aldoxime methiodide (2-PAM), in
conditions in which the reactivation of other enzymes would be insignificant . The other two
methods involved protection of the active centers of AChase from phosphorylation by labeled
DFP by use of 284C51, an inhibitor highly specific for this enzyme, or by use of eserine . Each
of these methods indicated that about 35% of the DFP-reactive sites at endplates of the
sternomastoid and diaphragm are AChase . The mean number of AChase molecules was thus
found to be 3.1 X 107 and 1 .1 X 107 per endplate in sternomastoid and diaphragm, respec-
tively. No significant reaction of labeled DFP with muscle and nerve was observed . Mast cells
in the muscle had a concentration of DFP-reactive sites far higher than the endplates .
665INTRODUCTION
The number and distribution of acetylcholines-
terase (AChase) molecules at individual motor
endplates must be known for any analysis, at the
molecular level, of the transmission processes at
these junctions. This number is considered here
for two mouse muscles ; the distribution of AChase
at endplates at the ultrastructural level in the
material described here has recently been reported
upon (Salpeter, 1967).
For the study of various enzymes, including
AChase, at the single cell level, valuable informa-
tion has previously been obtained by enzyme
histochemistry, with either the light or electron
microscope. This involves incubation of the tissue
in a medium containing a suitable substrate, and
precipitation of one of the products of enzyme
action as a detectable deposit. It is almost im-
possible, however, to deduce the amount of enzyme
present in a given structure from measurements
made on the deposited product. Ostrowski and
Barnard (1961) have suggested the use of isotopi-
cally labeled enzyme inhibitors as reagents, in an
alternative approach which is based on radioautog-
raphy, to demonstrate the distribution of radio-
activity-and hence of the enzyme-in the tissue .
In this method, measurement of the amount of
inhibitor bound by a given structure leads directly
to the number of enzyme sites present . One reagent
used for this purpose is di-isopropylfluorophos-
phate (DFP), a known inhibitor of AChase. This
reaction is irreversible, resulting in the formation
of a covalent bond with a serine residue at the
active center of the enzyme (see review by Cohen
and Oosterbaan, 1963) . It, therefore, takes place
in a I :1 ratio. DFP also phosphorylates a number
of other enzymes, including pseudocholinesterase
(Chase), chymotrypsin, a number of nonspecific
esterases, and a few other "active serine" enzymes.
It can only be made the basis for the measurement
of AChase in a given structure if its specificity is
adequately controlled by the parallel use of other
reagents specific for this enzyme . In this paper, we
report the measurement, firstly, of the total num-
ber of sites phosphorylated by DFP in motor
endplates of two muscles of the mouse. Secondly,
we determine the proportion of these sites that
represent AChase .
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Experimental Approaches
Previous work on the localization of DFP-
reacted enzymes by radioautographic techniques
has been based on the use of tritiated DFP and
grain density radioautographs (Ostrowski et al .
1963; Ostrowski et al ., 1964; Darzynkiewicz et al .,
1967). While the distribution and relative numbers
of enzymic sites phosphorylated by DFP can be
conveniently studied in this way, several factors
combine to make this method impractical for
measuring the absolute number of DFP-reactive
sites present in structures the size of motor end-
plates. DFP labeled with phosphorus-32 was
therefore used here for the latter purpose, and its
uptake into single endplates was measured by beta
track radioautography . Levinthal and Thomas
(1957) have demonstrated the quantitative preci-
sion of this technique in an elegant series of experi-
ments on the number of atoms of phosphorus in
single virus particles, and its potentialities have
been further explored by Levi et al. (1963) .
For the separation, from all the DFP-reactive
sites, of those sites that represent AChase, two
methods have been adopted . The first involves the
use of the compound pyridine-2-aldoxime
methiodide (2-PAM), developed in biochemical
studies as a specific reactivator of phosphorylated
AChase (Wilson and Ginsburg, 1955 ; Davies and
Green, 1956) . This nucleophilic oxime attaches
itself to the DP-AChase complex, removing the
DP-group and restoring activity to the enzyme.
(For recent reviews of the properties of 2-PAM, see
Koelle, 1963) . All the evidence available upon
2-PAM shows that it is highly specific for AChase,
restoring activity to pseudocholinesterase (Chase)
inhibited with organophosphorus compounds at
less than %iooo of the rate seen with AChase
(Wilson et al., 1958). The fraction of the labeled
endplate sites that could be reactivated by 2-PAM
was, therefore, taken to be the AChase contribu-
tion.
The second approach has involved protection of
true AChase with inhibitors more specific for this
enzyme than DFP itself. Thus, the Burroughs-
Wellcome compound 284051 (1,5-bis(4-allyl-
dimethyl-ammoniumphenyl) pentane-3-one dibro-
mide) is claimed to be a highly specific inhibitor
for AChase (Austin and Berry, 1953 ; Fulton and
Mogey, 1954 ; Bayliss and Todrick, 1956) . EserineTABLE I
The Basic Labeling and Washing Procedure Applied
to Muscle Fragments
Treatments 1-5 were applied in sequence, after
Koelle staining, with continuous agitation in each .
All solutions were in sodium phosphate buffer
(0.02 M, pH 7.4) . In later experiments, a 6th step,
a wash in 10 ml of 70% ethanol at 20 ° for 2 min,
was added.
is specific for both AChase and Chase (Augustins-
son, 1963) . AChase-active centers should be pro-
tected from reaction with DFP by the presence of
the specific inhibitor. Protection by such inhibitors
from labeling with DFP, and (independently) re-
activation of DFP-reacted sites by 2-PAM, have
been shown here to occur at the endplate sites, and
the results are demonstrated to be consistent with-
in themselves and with other evidence. The results
permitted the number of AChase molecules at the
endplate of mouse sternomastoid and diaphragm
muscles to be deduced.
A preliminary report of part of this work has
been published (Rogers et al., 1966) .
MATERIALS AND METHODS
DFP-32P and DFP-3H were obtained from the Radio-
chemical Center, Amersham, England, and from New
England Nuclear Corporation, Boston, at specific
activities of 40-90 mc/mmole (32P) and 1-4.3 c/
mmole (3H) . Nonradioactive DFP was obtained from
Sigma Chemical Co., St. Louis (and was handled with
the precautions due for its great toxicity) . DFP was
stored in dried propane-diol in sealed containers at
-35°C, and was used within 2 hr of dilution in
aqueous media.
Eserine and 2-PAM were obtained from Sigma . A
sample of 284C51 (mp 194-196 °) was kindly pro-
vided by Dr. H. T. Openshaw, Wellcome Research
Laboratories, Beckenham, Kent, England. Etho-
propazine hydrochloride ("Parsidol"®) was kindly
provided by the Warner-Lambert Research Institute,
Morris Plains, N. J., research affiliate of Warner-
Chilcott Laboratories . The tissue fixative was always
4 0/ 0 (w/v) formaldehyde in 0.027 M phosphate, pH
7.4, used at 4°C.
Labeling with DFP32P and Beta
Track Radioautography
32P- LABELING PROCEDURES : Male Swiss mice
(18-34 g) of unknown age were killed by a blow on
the head. Small fragments of the sternomastoid and
diaphragm muscles, from regions rich, in endplates,
were immediately dissected and placed in phosphate
buffer (0.02 M, pH 7.4) at 4°C. The endplates in
each fragment were then lightly stained by using an
acetylthiocholine technique (Pearse, 1961, p . 890)
modified from that of Koelle and Friedenwald (1949),
with incubation times of from 2 to 20 min. Follow-
ing staining, the muscle was fixed in formalin for
5-18 hr in most of the experiments . In the remainder
of the experiments, fixation was delayed until after
the labeling and washing procedures were com-
pleted.
The labeling and washing procedures used (except
where noted) were those described in Table I .
Barnard and Ostrowski (1964) have shown that
labeling in striated muscle reaches a maximum at
FIGURE 1 A microdissected length of muscle fiber,
showing the stained endplate on it. This material is the
type that was used in preparing the track radioauto-
graphs. In the majority of cases, the terminal axon
could be seen at the time of isolating the endplate for
radioautography, and the endplate always appeared to
be structurally complete . X 120.
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Solution Vol. Time Temp.
ml min °C
1 . DFP-32P at 10-4 M 1 .0 20 20
2. Phosphate buffer (X 2) 2 .0 2 20
3. Unlabeled DFP at 10-3 M 5 .0 10 20
4. Unlabeled DFP at 10-4 M 10 .0 20 0-4
5. Phosphate buffer (X 3) 20 .0 20 0-415-20 min, on incubation of small fragments in
radioactive DFP at 10-" M at room temperature.
BETA TRACK RADIOAUTOGRAPHY : After la-
beling, the fragments of muscle were transferred to
distilled water in an ice-cooled dish. Individual
lengths of muscle fiber were microdissected, some
bearing stained endplates (Fig. 1) and some without
endplates. Approximately 40 lengths of muscle fiber
were placed, by means of a pipette, on each gelatin-
ized slide, which was then allowed to dry. The tech-
niques we have employed for the track radioautog-
raphy, with Ilford G5 emulsion, are described in de-
tail by Rogers (1967) .
The mounted radioautographs were examined with
a Leitz Ortholux microscope, with either the KS X
53 or KS X 100 oil immersion objective . All the
track counts were made by two observers (A.W.R.
and K.O.) : there was no significant difference be-
tween counts made by either observer on the same
material.
Endplates were accepted for counting only if they
appeared histologically to be complete and un-
damaged. In addition, only those endplates on the
surface of a muscle fiber which faced towards the
emulsion were counted. In other words, if any part
of a stained endplate was seen to be in contact with
the microscope slide, and separated from the emul-
sion by its muscle fiber, that endplate was rejected .
The appearance of a beta track in Ilford G5 emul-
sion, and the grain spacing within these tracks, are
well documented (Levi et al ., 1963 ; Rogers, 1967).
A track was recorded only when it could be clearly
traced back to the area of tissue under examination .
In view of the wide separation of the muscle fibers on
the slides, the assumption was made that any track
that could be traced to the area of tissue under ob-
servation in fact entered the emulsion, rather than
left it, at that point.
For the case of 32P, self-absorption within the single
muscle fibers can be ignored (Roger, 1967) . It follows
that the beta tracks seen to enter the emulsion at a
stained endplate may, in fact, have originated in the
muscle fiber beneath that endplate . This muscle
background was estimated by counting the number
of beta tracks entering the emulsion from randomly
selected areas on the fiber lengths without endplates .
With a micrometer net in one eyepiece, the surface
area of each stained endplate was measured, and the
observed track count from that endplate was corrected
by subtracting the appropriate background value
from an equivalent area of muscle fiber alone .
THE CALCULATION OF THE NUMBER OF
SITES PHOSPHORYLATED PER ENDPLATE : For
a small source at the interface between glass and
nuclear emulsion, emitting beta particles in the
energy range of 32P, the tracks entering the emulsion
directly above the source represent one half of the
radioactive decays taking place during exposure
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(Rogers, 1967). Having excluded endplates that were
buried beneath their muscle fiber or otherwise
shielded from direct contact with the nuclear emul-
sion, we made the assumption, in our calculations,
that this same factor relates the observed track counts
from the areas occupied by stained endplates (after
correction for muscle background) to the disintegra-
tions within the endplate during exposure. For beta
particles from 32P, less than 1 % will fail to produce
recognizable tracks (Rogers, 1967). The disintegra-
tion rate per hour per endplate (D) can, therefore, be
calculated from the track count observed at the end-
plate (TE) and that found for an equal area of muscle
fiber alone (TM) by the equation:
D = (TE - TM) 2
h
where h is the exposure time in hours . After correcting
for radioactive decay, calculated to the midpoint of
exposure, we can readily convert the disintegration
rate into the number of DP32P groups that have been
introduced, since the specific activity of the DFP-32P
is known.
Labeling with DFP-3H and
Grain-Density Radioautography
Small fragments of muscle were fixed in formalin,
and then labeled by one of the procedures specified
in the text. Sections of muscle were then cut at 5 .s
on a cryostat (American Optical Co., Buffalo),
mounted on gelatinized slides, and radioautographed
either by the stripping film technique, with Kodak
AR-10 film (Pelc, 1956), or by dipping the slides in
Ilford K2 nuclear emulsion (Rogers, 1967) . Expo-
sure times averaged 2 wk. Following development,
fixation, and washing, the slides were immersed in a
solution of 2-PAM at 10-2 M for 20-30 min, and then
stained for the presence of AChase by the method of
Karnovsky and Roots (1964) . In spite of the radio-
autographie procedures, it was possible to produce
sufficient staining in these sections to enable endplates
to be positively identified (Fig. 2).
In one experiment, the muscle was stained by the
cs-naphthyl acetate technique for demonstrating non-
specific esterase (Pearse, 1961), which also enables
endplates to be positively identified (see Hopsu and
Pontinen, 1964). This material was labeled after
staining. The cryostat sections were mounted on
gelatinized slides, and then covered with a thin but
impermeable membrane of polyvinyl chloride (PVC),
according to the technique of Sawicki and Darzyn-
kiewicz (1964). The radioautographic emulsion was
applied over this membrane.
The grain counts in the material labeled with
DFP-3H were all performed by one observer (Z . D.)FIGURE 2 Photomicrographs of a section of diaphragm after labeling with DFP 3H, to show a stained
endplate : (a) by transmitted light, (b) by dark-field incident illumination. It can be seen that the silver
grains in the radioautograph (reflecting, in b) are at a higher density over the endplate than over surround-
ing muscle fibers. The endplate is positively identified by staining (after 2-PAM treatment), by the
Karnovsky and Roots (1964) method, through the emulsion after radioautography . Radioautograph pre-
pared with Ilford K2 emulsion. X 1,200.
using a Leitz Ortholux microscope equipped with a
Pl. Apo. X 100 objective and X 10 eyepieces . The
grains were viewed by transmitted and vertical inci-
dent light alternately (Rogers, 1967), for distinguish-
ing them with certainty from the deposited stain.
Corrections for background were made on the basis
of grain counts over adjacent areas of muscle fiber .
Labeling with DFP-3H and Electron
Microscope Radioautography
The sternomastoid muscles of one mouse were
fixed in situ by treatment with cold 1 % glutaralde-
hyde in phosphate buffer. Small fragments rich in
endplates were dissected out, and fixation in cold
glutaraldehyde continued for a further 3 hr . After
being washed in buffer, this material was labeled by
using the procedures "DFP-3H-2-PAM" or "DFP-2-
PAM-DFP-3H" (Table IV). After postfixation in
Os04, electron microscope sections were prepared
and radioautographed with Ilford L4 and Kodak
NTE emulsions, by the techniques described by
Salpeter (1967).
Staining Procedures for Demonstration
Mast Cells
Small muscle fragments were fixed in formalin in
the usual way, and then treated with ethylene glycol
monoethyl ether, according to the technique of
Guidotti and Spinelli-Rossi (1963) . These fragments
were labeled (Table I) with DFP-3H, and then sec-
toned on a cryostat at 5 ,u and radioautographed .
After photographic processing, the sections were
stained with toluidine blue (0.025 % in acetate buffer
at pH 4.5) for 30 min at 0 °C. Mast cells showed clear
metachromatic staining .
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Measurement of the Total Number of DFP-
Reactive Sites per Endplate
Diaphragm and sternomastoid muscle speci-
mens were treated with DFP32P to label endplates.
Radioautographs of microdissected single end-
plates were then prepared (Fig. 1). Beta tracks
numbering not more than 10 per endplate could be
clearly seen entering the emulsion from the end-
plate, at the exposure times used (Figs. 3 and 4).
Table II lists the calculated values for the num-
ber of molecules of DFP-32P bound per endplate
for all the available experiments. In addition, a
number of factors which differed, from one experi-
ment to another, are listed. With the sternomas-
toid muscle in particular, a wide range of values
was found, 0.78-8.6 X 107 molecules per end-
plate. This variation is large relative to that occur-
ring within each experiment (Table II, last
column). The factors that varied among the experi-
ments were, therefore, examined to identify the
source of this variation.
FIGURE 3 A beta track radioautograph, showing two
tracks of silver grains formed by beta particles enter-
ing the emulsion from the stained endplate. X 1,200.
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FIGURE 4 A beta track radioautograph showing several
tracks in the vicinity of a stained endplate . When the
focus was changed, these tracks could all be traced back
to the endplate itself. X 1,200.
THE EFFECT OF PRIOR TREATMENT WITH
UNLABELED DFP : In Exp . 4, the fragments
of sternomastoid muscle, with and without
endplates, were separated into two groups . One
group was preincubated in unlabeled DFP at
10-4 M for 20 min at room temperature, and both
groups were then labeled by the standard (Table
1) procedure. Without the preblocking, the end-
plates showed a track count significantly above the
level in muscle fibers alone. No such difference was
seen in the other group, however, in which all the
sites of phosphorylation had presumably been
blocked by the initial treatment with unlabeled
DFP (Table III) . It would seem reasonable to infer
that differences in track density between endplates
and muscle fibers without endplates reflect dif-
ferences in the numbers of sites available for phos-
phorylation by DFP, and are independent of
nonspecific adsorption of DFP-12P. It is interesting
to note that the muscle background was actually
higher in the material preblocked with unlabeled
DFP. The value for muscle background represents
adsorbed radioactivity not removed by the wash-TABLE II
Variation with Conditions of Labeling of the Apparent Numbers of DP-Groups per Endplate
ing procedure in both groups of material . Small
differences in the size and shape of the individual
fragments could influence the efficiency of wash-
ing. In all the material presented, therefore,
measurements of muscle background are taken
on fibers from the same fragment as the endplates .
THE SATURATION OF AVAILABLE REAC-
TIVE SITES BY DFP-32 P : Two methods were
used to determine whether the standard expo-
sure of 20 min, at room temperature, to DFP-
32P at 10' M was sufficient to saturate all available
reactive sites in the endplates. In Exps. 8 and 9
(Table II), the time of exposure was extended to
The experimental variables which might have contributed to the relatively wide
scatter of apparent values are listed . The values in the last column are regarded as
acceptable values, obtained by correcting (see text) the apparent values for the effects
of prior staining : Each value is given as the mean and its standard error, and the num-
ber of endplates used is noted in parentheses. Exps. 4, 14, 16, and 18 b have been ignored
there because of the native chemography associated with the longer exposure periods;
Exp. 17 is ignored because of the short labeling time used.
* All were labeled as shown in Table I except for those in this experiment, in which
DFP-32P at 10-3 M was used.
30 min. These experiments were comparable in all
other respects with Exp. 15 b for sternomastoid :
the results were very close . With the diaphragm,
no complete matching of these experiments was
available, but all the values obtained with this
muscle are reasonably close.
In Exp. 6, DFP32P was applied at 10-3 M, and a
value of 4.0 X 107 molecules DFP reacted per
sternomastoid endplate was obtained . Exps. 5, 7,
and 12 matched Exp. 6 in every respect except for
the lower concentration of DFP 32P, and gave
values of 3.4-5.2 X 107 molecules per endplate.
It is reasonable to assume that all available sites
ROGERS ET AL . Quantitative Studies on Enzymes. I 671
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Experiment
	
labeling
time
Fixation Staining
time Exposure
DP-groups (X 10- 7) per endplate
Apparent Corrected
min min hr
A. Sternomastoid muscle endplates
4 20 After 10 66 2 .6
5 20 After 10 18 3 .4 6 .2 f 1 .1 (18)
6 20* After 10 18 4.0 7 .3 f 0.8 (18)
7 20 After 10 17 .5 5 .2 9 .5 zh 1 .6 (13)
8 30 Before 5 20 4.9 6 .5 f 0.7 (15)
9 30 Before 5 20 6 .9 9 .2 t 1 .6 (28)
12 20 After 10 1,8 4.4 8 .0 t 1 .2 (47)
14 20 Before 5 45 1 .9
15 a 20 Before 2 21 8 .6 9 .5 f 3 .6 (13)
b 5 8.6 11 .4 ± 1 .9 (9)
c 10 6 .0 10 .9 ± 2 .4 (12)
d 20 0 .8 10 .0 t 0 .9 (22)
16 20 Before 5 44.5 1 .9
17 16 Before 10 21 2 .2
18 a 20 Before 10 15 4 .7 8 .5±1 .2(45)
b 39 3 .6
B. Diaphragm muscle endplates
10 17 .5 2 .0 3 .6 f 0 .4 (37) 7 20 After
8 30 Before 5 20 1 .9 2 .5 f 0 .3 (23)
9 30 Before 5 20 2 .3 3 .1 ± 0 .8 (17)
11 20 After 10 18 1 .6 2 .9 f 0 .7 (38)
12 20 After 10 18 1 .6 2 .9 f 0 .4 (73)TABLE III
Labeling Seen on Muscle Fibers Bearing Endplates
and on Fiber Lengths without Endplates
There were 22 endplates or fibers in each group .
After the usual labeling procedure, endplates
showed a highly significant track count relative to
background fibers (a). In material treated with
nonradioactive DFP before labeling, there was no
significant difference between endplates and back-
ground fibers (c) . Even when the counts were aver-
aged over the whole length of the fiber in question,
there is still a significant difference from back-
ground due to the presence of an endplate (b) ; this
is not so when the material is preblocked (d) .
at the endplate are phosphorylated in the condi-
tions listed in Table I, as suggested by Barnard and
Ostrowski (1964) .
THE EFFECT OF PRIOR FIXATION ON PHOS-
PHORYLATION WITH DFP- 32 P In the ma-
jority of experiments listed in Table II, the
muscle fragments were fixed with formalin before
phosphorylation with DFP-32P. It is possible that
fixation could inactivate enzymes present at the
endplate, reducing the apparent uptake of radio-
activity. Therefore, in a series of experiments
(Nos. 4, 5, 6, 7, 11, and 12), fixation was postponed
until after the labeling with DFP32P. If we con-
sider the sternomastoid results, Exps. 5, 6, 7, and
12 form a group which is directly comparable in
every respect with Exps . 15 e, 17, and 18 a.
The mean value from the group of experiments
in which the muscle was fixed prior to labeling was
4.28 X 107 molecules per endplate. The mean
value from the groups in which fixation followed
labeling was 4.25 X 107 molecules per endplate .
There is thus no evidence for loss of enzymic sites
through prefixation in formalin .
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LATENT IMAGE FADING : Fading of the la-
tent image in the silver halide crystal (see Rogers,
1967) may occur (particularly in the presence of
moisture and of atmospheric oxygen) . It may be
troublesome with relatively long exposure times, of
the order of several weeks, but the longest exposure
in these experiments was 66 hr .
Latent image fading affects track radioauto-
graphs by reducing the density of silver grains
along the course of those tracks formed early in
exposure. There is a stage at which these tracks
with widely spaced grains can, nevertheless, be
recognized, whereas more severe fading will make
it impossible to link up the remaining grains into a
continuous track. The tracks seen throughout the
emulsion were carefully examined with the possi-
bility of fading in mind. The grain spacing ob-
served was fully consistent with that described by
Levi et al. (1963) . It is, therefore, assumed that
generalized latent image fading did not occur in
this material, a result that would be predicted from
the efforts made to control the humidity and, in
later experiments, to exclude atmospheric oxygen
during the short exposure periods .
NEGATIVE CHEMOGRAPHY : This is (see
Rogers, 1967) an artifactual, chemically induced
decrease in developable grains, in the immediate
vicinity of the tissue responsible . It was found in
several experiments in which the exposure time
exceeded 24 hr. This effect persisted, in spite of
efforts to dry the emulsion and to exclude atmos-
pheric oxygen during exposure. In Exp. 18, identi-
cal material was exposed for periods of 15 and 39
hr. From the 45 endplates examined at the shorter
exposure time, a value of 4 .67 X 107 molecules per
endplate was obtained ; 27 endplates at the longer
time gave 3.64 X 107 molecules per endplate.
Of the experiments in Table II in which the
staining time was 10 min (excluding Exp . 17, in
which the labeling time was only 16 min), eight
experiments are comparable in every respect, save
the length of radioautographic exposure. The
values obtained from exposures of 39 and 66 hr are
lower than the values in the other experiments, in
all of which the exposures were for less than 24 hr .
Similarly, with 5-min staining, there are five ex-
periments which form another comparable group .
Here, the reduction in the calculated number of
molecules per endplate is even more marked in the
material exposed for more than 24 hr.
This negative chemography affected the track
counts from the muscle fibers without endplates
Material
Endplate Background
fiber
	
fiber
Group I: DFP-23P labeling
a. Tracks per endplate or 6 .3 1 .4
equivalent area
b. Tracks per unit length of 1 .7 1 .1
fiber
Group II: Pretreatment with un-
labeled DFP
c. Tracks per endplate or 1 .0 0 .7
equivalent area
d. Tracks per unit length of 1 .6 1 .6
fibera
0
	
4
	
3
FIGURE 5 A graph to illustrate the effects of prestaining the endplate by the Koelle reaction for various
periods on the observed uptake of DFP at the endplate. O, mean values from Experiment 15 ; •, the
mean values from each of the other experiments on sternomastoid endplates (after excluding those experi-
ments with exposure times longer than 24 hr or incubation times in DFP- 32P of less than 20 min) .
just as much as the counts from endplates them-
selves. It is unlikely to be due to the colored
precipitate of the Koelle reaction, therefore.
In view of this artifact, all experiments with
exposure times longer than 24 hr should be ex-
cluded from calculations of the absolute number of
molecules of DFP reacting per endplate (Table
II) . These experiments are, nevertheless, valid for
the estimation of the relative numbers of sites
phosphorylated under different conditions . There
is no correlation between the exposure time and the
calculated number of DP 32P groups per endplate
for exposures of less than 24 hr . This supports the
qualitative observation that the grain spacing in
tracks immediately adjacent to the tissue seemed
normal in this material.
THE EFFECT OF THE KOELLE REACTION
ON REACTION WITH DFP- 32P : All the ma-
terial examined was stained by the Koelle reaction
for AChase in order to identify the motor end-
plates. This was necessary both at the stage of
microdissection and in scanning the completed
radioautographs. This staining had to be carried
out prior to labeling with DFP 32P, as phosphoryla-
o
10
	
20
Staining time (min)
tion inhibits the enzyme and abolishes the color
reaction. No other staining method is known for
motor endplates which is not also abolished by
treatment with DFP. To use endplates in un-
stained material was not desirable, because of the
risk of overlap between the track densities from the
least heavily labeled endplates and from the most
highly labeled areas of muscle fiber.
The investigation of the effects of staining was,
therefore, limited to the comparison of results
after incubation for different periods of time in the
medium containing acetylthiocholine . In Exp. 15,
material which was otherwise identical was incu-
bated in the Koelle medium for 2, 5, 10, and 20
min. The apparent values thus obtained for the
number of sites phosphorylated by DFP31P per
sternomastoid endplate, together with the mean
values obtained from all the other experiments in
which the exposure times were less than 24 hr, are
plotted in Fig. 5.
There is an obvious reduction in the number of
labeled molecules per endplate in the sternomas-
toid muscle with increasing incubation time in the
staining medium. This effect is similar but less
ROGERS ET AL . Quantitative Studies on Enzymes . 1
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I.noticeable in the fewer results from the diaphragm .
The decrease with time appears to be approxi-
mately linear, and extrapolation to zero time gives
a value of about 9.0 X 107 DFP-sensitive sites per
endplate for the sternomastoid, and about 3 .0 X
107 sites per endplate for the diaphragm .'
THE NUMBER OF DFP-REACTIVE SITES
PER ENDPLATE : In calculating this number,
we excluded all experiments with radioautographic
I In recent experiments of Dr. J. Wieckowski (to be
published) in this laboratory, it has been shown that,
with improved procedures, small fibers each bearing
one endplate can be obtained from rodent sternomas-
toid muscle without any staining treatment whatso-
ever. These endplates have been identified, after the
dissection, by the presence of the afferent terminal
nerve fiber. Tracks can be unambiguously counted for
these endplates, removing the difficulty discussed
here. A modified version of the acetylthiocholine-
staining reaction has also been employed which, with
short incubations, has been found to permit the
localization of the endplates, as in the present work,
but does so without retardation of the DFP reaction .
The value for the number of DFP-reactive sites per
mouse sternomastoid obtained by track radioautog-
raphy with either of these new methods is not signifi-
cantly different from the value already obtained by
the extrapolation (Fig. 5) in our stained material.
Hence, the assumption used in the present work has
been independently validated.
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TABLE IV
The Percentage of DFP-Reactive Sites per Endplate that Could be Reactivated by 2-PAM
exposures longer than 24 hr, in view of the negative
chemography experienced with this material. Exp.
17 was also excluded, since the time of incubation
in DFP 32P was only 16 min. This time is too short
in our conditions to give saturation of all available
DFP-reactive sites (Barnard and Ostrowski, 1964).
The values of the apparent number of DP-
groups per endplate for all the remaining experi-
ments were corrected for the effects of prior stain-
ing. These corrected results are listed in the final
column of Table II. They suggest that each sterno-
mastoid endplate contains 6.2-11.4 X 107 sites
that can be phosphorylated with DFP. Diaphragm
endplates contain 2.5-3.6 X 107 sites.
Measurement of the Contribution of AChase to
DFP-Reactive Sites at Endplates
Experiments to determine the percentage of
DFP-reactive sites that can be considered active
centers of AChase were carried out by beta track
radioautography, following labeling with DFP 32P,
and by grain-density techniques after DFP 3H .
TRITIUM LABELING OF ENDPLATES : Dia-
phragm muscle specimens were treated with
DFP3H and radioautographs were prepared
which showed that grain densities over the sec-
tioned endplates (Fig. 2) were well above those
over muscle fibers alone . If we take into account
the specific activity of the DFP 3H and the length
In each experiment, a group of endplates was treated by the sequence indicated, and a
parallel group by the DFP-32P (or DFP-3H) basic procedure. The measurement for the
reactivated sites (determined by subtraction, except in the experiment of the last line)
is expressed as a percentage of that for the total sites, per endplate . In the beta track
material, each group comprised 12-48 endplates ; in the grain density material, grain
counts were taken from 50 or 100 sectioned endplates in each group .
* Material stained by the a-naphthyl acetate reaction.
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Muscle Treatment Radioautographic
technique
Sites
sensitive to
2-PAM
%
Sternomastoid DFP-32P-2-PAM Beta track 33
37
Diaphragm DFP-32P-2-PAM Beta track 37
DFP-3H-2-PAM Grain density 36
33
46*
DFP-2-PAM-DFP-3H Grain density 31 *20
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40
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60
0
INCUBATION IN 2-PAM(min)
FIGURE 6 A graph to show the time-course of reactivation of DFP-labeled endplates by 2-PAM. The
solid circles represent track counts on material labeled with DFP-32P: each group comprised 14-24 end-
plates, giving a standard deviation which was between 0 .18 and 0.34. The open circles represent grain
counts on material labeled with DFP 3H : each group comprised 100 sectioned endplates .
O IO
of exposure in each experiment, the grain densities
were compatible with the densities predicted on
the basis of the number of sites of phosphorylation
by DFP (as measured above) and with the esti-
mates of grain yield for tritium radioautographs
available in the literature (Barnard and Marbrook,
1961 ; Kisieleski et al., 1961 ; Falk and King, 1963) .
In the absence of a firm estimate of the grain yield
from tritium in our experimental conditions, no
attempt has been made to calculate the absolute
number of sites from the 3H-labeled material.
In one experiment, the a-naphthyl acetate color
reaction was used to stain endplates in fragments of
diaphragm, before labeling with DFP-3H. This
method for nonspecific esterases gives noticeably
more intense staining at endplates than in muscle
generally, an effect that is abolished by treatment
with DFP prior to staining. The cryostat sections
of muscle stained in this way were covered with a
protective membrane of PVC before coating with
liquid emulsion, for preventing possible chemogra-
phy from the stain and protecting the stain during
photographic processing. The unknown thickness
of the membranes introduced a source of variation
into this experiment which was not present in those
cases in which staining took place through the
emulsion after processing. Differences in thickness
in membranes covering different slides were ran-
domized by counting from several slides in each
group; the results of this experiment are included
100
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80 ei
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in Table IV, where they can be seen to be in line
with those of the other experiments (see below).
REACTIVATION OF PHOSPHORYLATED
ACHASE BY 2-PAM : Two complementary pro-
cedures were used in these experiments : in both,
the labeling over an experimental group of end-
plates was compared with that over endplates
labeled directly with radioactive DFP . The first
procedure involved labeling with radioactive DFP,
followed by incubation in 2-PAM to remove
labeled DP-groups from AChase alone, and is
designated DFP 3H-2-PAM. The second involved
treatment with nonradioactive DFP, followed by
2-PAM and radioactive DFP, and will be referred
to as DFP-2-PAM-DFP3H . In either procedure,
DFP3H may be replaced by DFP 3 2P. The first
procedure labels all DFP-reactive sites except
AChase, whereas the second procedure labels
AChase alone.
The time--course of reactivation by 2-PAM was
first determined (Fig . 6) with the routine DFP 3H-
at room temperature, the radioactivity initially
present at the endplate decreases for the first 15-20
min, and then remains relatively constant, even
after incubation in 2-PAM for 60 min . Approxi-
mately one-third of the radioactivity at the end-
plate is removed in incubation times of 20 min or
more.
Table IV summarizes the results obtained by
the use of 2-PAM. In endplates of both the sterno-
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Labeling Procedures Employing Reactivation by 2-PAM or Protection by Inhibitor
mastoid and the diaphragm, the proportion of sites
sensitive to 2-PAM was about 35% . This value
was independent of the isotope, the labeling se-
quence, and the radioautographic method . It was
not altered when the identity of the labeled end-
plate was checked by the naphthyl acetate staining
method. For these reasons, therefore, it is con-
cluded that about one-third of the sites phos-
phorylated by DFP at motor endplates is AChase .
PROTECTION OF CHOLINESTERASE BY SPE-
CIFIC INHIBITORS : The proportion of AChase
sites among the DFP-reacted sites was also de-
termined by protection of the latter by inhibitors
more specific for AChase than DFP itself. Those
inhibitors used were the Burroughs-Wellcome com-
pound 284C51, and eserine (see Introduction) ; the
inhibitor was present before, during, and after the
labeled DFP reaction (Table V). With either
DFP3H or DFP32P, each of two different experi-
ments with the anti-AChase 284C51 showed
(Table VI) protection of about one-third of the
total DFP-reactive sites at each endplate, while one
experiment showed protection of about one-half of
these sites. Eserine, which inhibits both AChase
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+ Chase)
(Ethopropazine) All sites except
Chase
In some experiments, DFP- 3H was substituted for DFP- 32P (with the Koelle staining then postponed : see
Methods), and grain density techniques were substituted for beta track radioautography . All solutions were
made up in sodium phosphate buffer (0 .02 M at pH 7 .4) except those marked *, which were at pH 7 .9 (0 .02 M
phosphate buffer) . The 2-PAM treatment, and the two subsequent rinses in phosphate buffer, were each
for 20 min at 20° . In later experiments, brief extraction in 70% ethanol followed the final wash in phos-
phate buffer. The headings are used in the text to designate these entire procedures (with DFP- 3H re-
placing DFP-32P, where used) . The concentrations of inhibitor were always 3 X 10-5 M (for 284051 or
ethopropazine) or 10-5 M (eserine) .
and Chase, again protected one-third of the sites in
the diaphragm endplate that are reactive to
labeled DFP (Table VI).
Ethopropazine (lysivane) is specific (see Discus-
sion), at the concentration used here, for Chase .
The results, after protection by this compound
(Table VI), for the cases of the sternomastoid and
the diaphragm endplates are not in very close
agreement, but all of the three determinations
made show that only low amounts of Chase are
present. More experiments would be needed to
determine these figures accurately. If we take into
account the failure of eserine to protect more sites
from reaction with DFP than 284051 protected, it
is clear that relatively few of these sites can be
attributed to Chase, a conclusion supported by
these experiments with ethopropazine.
DFP-Reactive Sites in Structures Other than
Motor Endplates
The labeling seen in striated muscle in these
experiments was variable, and it was low relative
to that in endplates. We attribute most of this
DFP-32P-2-PAM DFP- 2-PAM--DF P-3'-P Inhibitor protection
1-5. Labeling and washing as 1 . Unlabeled DFP at 10-4 M 1 . Inhibitor
in Table I 2. Phosphate buffer (X 2) 2 . DFP 32P at 10-4 M + inhibitor
6 . Phosphate buffer* 3. Phosphate buffer* 3. Phosphate buffer (X 2) + in-
7. 2-PAM at 10-3 M* 4 . 2-PAM at 10-4 M* hibitor
8. Phosphate buffer (X 2)* 5. Phosphate buffer (X 2) 4. Unlabeled DFP at 10-3 M + in-
6-10. As in Table I (1-5 .) hibitor
5. Unlabeled DFP at 10-4 M + in-
hibitor
6 . Phosphate buffer (X 3) + in-
hibitor
Labeled: All sites except AChase only (284C51) All sites except AChase
AChase (Eserine) All sites except (AChaseTABLE VI
The Proportion of Sites per Endplate Protected from Phosphorylation by Specific
Enzyme Inhibitors
In each experiment, a group of endplates was treated by the sequence indicated (see
Table IV, last column) and a parallel group by the basic DFP-32P (or DFP-3H) pro-
cedure. The measurement for the former (protected) group is expressed as a percentage
of that for the latter. In the beta track material, each group comprised sections of 50
or 100 endplates . In the experiments marked *, the incubation period of the material
in DFP-32P was 16 min, instead of the usual 20 min.
radioactivity to adsorbed DFP rather than to sites
that are phosphorylated irreversibly. The variation
seen could be related to the extent and nature of
the washing process after labeling. When a wash in
organic solvents (Rogers and Barnard, 1969) was
given, the muscle background was reduced, but
some persisted. There are almost certainly esterase
sites in muscle fibers at which DFP reacts, but they
must be at a very low concentration since it was
not possible to measure them in this material .
Similarly, no appreciable labeling above muscle
background was observed in the peripheral nerves
of this material . Salpeter (1967) has found only
very low levels of labeling in muscle and in nerve in
similar specimens, prepared in parallel to these, for
electron microscope radioautography : the labeling
over the terminal axon region was not above 2 % of
that in the junctional fold region .
REACTION OF DFP WITH ENZYMES IN MAST
CELLS : In grain-density radioautographs of
muscle sections following labeling with DFP3H,
scattered but discrete areas which were highly
radioactive were often encountered. These areas
did not correspond in position or number with the
distribution of endplates (Fig. 7). The labeling did,
however, reflect phosphorylation with DFP, since
it was abolished by pretreatment with nonradio-
active DFP. This labeling was absent in control
radioautographs of unlabeled muscle, but was
present, again distinctly stronger than at the
stained endplates, in radioautographs in which a
thin PVC film (Sawicki and Darzynkiewicz, 1964)
was interposed over the tissue, showing that no
form of chemography was responsible for it. In
material fixed and processed in the normal way,
cytological detail in these heavily labeled structures
was not well preserved, so that their identification
was difficult then . These structures were eight to
ten times more heavily labeled than endplates,
after the direct treatment with DFP 3H.
In material viewed by electron microscope
radioautography, these highly radioactive struc-
tures were also seen (Fig . 8), and had the appear-
ance characteristic of tissue mast cells.
Material was prepared by postfixation in ethyl-
ene glycol monomethyl ether (Guidotti and
Spinelli-Rossi, 1964), which better preserves the
cytoplasmic granules of mast cells . After toluidine
blue treatment of this material, all the highly radio-
active areas corresponded to granular cells with
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Muscle Inhibitor Radioautographic
technique
Sites
protected Enzyme protected
0/ 1
Sternomastoid 284C51 Beta track 51* AChase
Diaphragm 284C51 Beta track 31 AChase
Grain density 34 AChase
Diaphragm Eserine Grain density 34 AChase
+ Chase
Sternomastoid Ethopropazine Beta track 5* Chase
Diaphragm Ethopropazine Grain density 16 Chase
12 Chasemetachromatic staining (Fig. 9), confirming that
these structures were mast cells .
DISCUSSION
The Nature of the Endplate Sites Labeled
by DFP
The radioactivity measured in endplates, after
the subtraction of the background due to the
muscle fiber itself, has well defined characteristics .
It is completely absent in material treated with
unlabeled DFP at 10' M for 20 min before the
labeling procedure. It persists, however, through a
long and thorough washing, which includes ex-
change with unlabeled DFP at 10-3 and 10-' M.
These features eliminate the possibility that merely
adsorbed isotopic material is being measured. The
absolute number of molecules of DFP-32P repre-
sented by this radioactivity is reasonably constant
in different animals, and in different experiments
in which the background levels of radioactivity in
678
FIGURE 7' A radioautographic section of DFP 3H-treated, Koelle-stained diaphragm that contains both
an endplate and one of the sites of high grain density . In a (transmitted light), the endplate is recognized by
its staining. In b (reflected light), only the silver grains are seen, and are shown to be heavier over the non-
stainable structure.
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the muscle varied considerably. It is independent
of formalin fixation, and of increases in either the
concentration or the time of incubation in DFP-
32P. The conclusion that this technique is measur-
ing all the sites within the endplate at which the
phosphorylation with DFP 32P can take place is
difficult to avoid.
Such irreversible phosphorylation occurs, at the
low DFP concentrations and reaction times that we
have used, only at the active centers of certain
esterases (Cohen and Oosterbaan, 1963), and not
at other proteins : the specificity of this treatment
for the serine esterases has been discussed in detail
elsewhere (Barnard and Rogers, 1967).
The Validity of the Quantitative Measurements
Although every effort was made to count only
from endplates that appeared to be undamaged,
the terminal portion of the motor nerve could not
always be seen, and hence minor degrees of dam-
age cannot be excluded . In this context, it is in-FIGURE 8 Electron microscope radioautograph of a section of sternomastoid muscle, after the DFP 3H-
i-PAM treatment. Coated with a monolayer of centrifuged Kodak NTE emulsion; developed with gold
latensification-Elon-ascorbic acid ; 11 days of exposure . Labeling is seen to be confined to granules in a
mast cell, and is not over muscle fibers . X 14,000 .
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679FIGURE 9 A radioautographic section of DFP 31I-
treated diaphragm, preserved with ethylene glycol
monoethyl ether, and stained with toluidine blue. A
metachromatic cell is shown, coinciding with a site of
high grain density.
teresting to note that approximately 80% of the
AChase at the endplate is situated in the junctional
fold region, presumably in the postsynaptic mem-
brane (Rogers et al., 1966 ; Salpeter, 1967). It is
thus unlikely that minor degrees of damage to the
terminal axon and its surrounding Schwann cells
would significantly reduce the total number of
sites of phosphorylation in the endplate .
The negative chemography encountered in the
present experiments may have been due to the
formalin fixation. Having established that formalin
fixation did not inactivate any of the sites being
studied, we found it preferable to control this
artifact by keeping emulsion exposure periods
shorter than 24 hr, rather than to investigate alter-
native fixatives . In one other experiment (details
given by Barnard and Rogers, 1967), glutaralde-
hyde was found to reduce the number of sites
phosphorylated by DFP by about 10%
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The Effect of Staining on the DFP Reaction
The inhibition of phosphorylation by DFP, pro-
duced by the Koelle reaction, is remarkable. It
may be that the precipitate accumulating at the
enzyme sites physically impedes the access of
DFP. This might be expected to give the approx-
imately linear type of relationship seen in Fig . 5. If
this is the correct explanation, the extrapolation of
this curve to zero time would be an acceptable
method of estimating the number of sites that
would have been phosphorylated in the absence of
staining. Since these measurements were made, the
validity of this estimate obtained by extrapolation
has been confirmed by track measurements
(Wieckowski and Barnard, in preparation) on
sternomastoid endplates labeled without stain-
ing (see Footnote 1). It will be shown in the suc-
ceeding paper (Rogers and Barnard, 1969) that
liquid scintillation counting of isotope from
DFP 3H-reacted diaphragm strips, stained and
unstained, gives results that provide an in-
dependent confirmation of the results of the extrap-
olation in Fig. 5.
This inhibiting effect of the Koelle reaction has
interesting consequences for histochemical tech-
niques based thereon. It is clear that sites of high
activity would soon become inhibited, due to the
initially rapid buildup of deposit. Sites at which the
enzyme is less concentrated, however, might be
expected to continue to accumulate end-product .
Any comparisons that are made between the
amounts of enzyme present in different sites from
the amount of deposit seen should take account of
this, and should obviously be based on the shortest
possible incubation times.
Variability and Reproducibility
The fairly wide scatter of mean values found in
the various experiments conducted under appar-
ently similar conditions, and the variation found
within each experiment, can, in part, be attributed
to this effect of staining. At microdissection, the
endplates at the surface of the fragment were often
more heavily stained than the endplates within the
fragment. Presumably, diffusion of acetylthiocho-
line into the fragment limited the rate of deposition
of end-product at more centrally placed endplates.
Although endplates that were clearly stained were
usually dissected from the surface of the block, no
deliberate attempt was made to restrict dissection
to this region. We have not seen, however, in anyof the work reported in this series, any evidence for
difficulty of diffusion of DFP itself into muscle
specimens of the size we have used : the charged
substrate (and the metal) can be expected to differ
from the lipophilic DFP molecule in this respect.
A further cause of variability can probably be
identified in the mice. In Exp. 18, sternomastoid
endplates from two mice were processed separately
instead of being pooled, as in previous experi-
ments. The track counts in 35 endplates counted
from the first mouse were approximately one-half
the track counts seen in the 37 endplates from the
second mouse, in conditions that were identical.
This individual variation is interesting and de-
serves further investigation.
The data permit, nevertheless, the estimation of
the total number of DFP-reactive sites per endplate
in the two muscle types studied, at the levels shown
in Table II. Since the fraction of these sites that is
AChase has been determined (Tables IV and VI),
the absolute numbers of AChase molecules per
endplate in these muscles are now available (Table
VII). These are, strictly, the numbers of active
centers of AChase. AChase purified from other
sources can exist as aggregates of varying numbers
of active units (Kremzner and Wilson, 1964;
Changeux, 1966) . Since the quaternary structure
of the endplate AChase is unknown, we use
"AChase molecule" for the unit with one active
center, since this is the entity of the most direct
physiological interest.
Reactivation with ,2-PAM and "Ageing"
When DFP is reacted with AChase, the diiso-
propylphosphoryl (DP-) portion of the DFP mole-
cule becomes covalently bound to the serine
residue at the active center of the enzyme . With
time, a process known as "ageing" occurs, in
which one isopropyl group becomes hydrolyzed
from the molecule (Behrends et al., 1959). The
inhibited AChase cannot be reactivated by 2-
PAM after "ageing" has taken place. (For a full
discussion of this phenomenon, see Hobbiger,
1963).
It is clear that "ageing" of the DP-AChase
would reduce the proportion of sites apparently
sensitive to 2-PAM in these experiments. The in-
formation available in the literature suggests that
the half-time of "ageing" of DP-AChase is 2-3 hr
at 37°, 10-12 hr at 20°, and some days at 0 ° (Hob-
biger, 1956; Davies and Green, 1956 ; Latki and
Erdmann, 1961) . Evidence from our material that
TABLE VII
Numbers of DFP-Reactive Sites and of AChase
Molecules at Endplates
* From results of all the experiments of Table II
(last column) .
$ On the basis of a mean of 35% for the proportion
of AChase in the DFP-reactive sites .
is consistent with this evidence is reported in the
succeeding paper (Rogers and Barnard, 1969) .
In the experiments reported here, the tissues
were held at room temperature for about 35 min,
and were then held at 0-4 ° for a further 3-4 hr,
from the beginning of treatment with labeled DFP
to the start of reactivation with 2-PAM . It is,
therefore, unlikely that "ageing" significantly
affected these measurements. It is interesting also
that the results obtained by reactivation with 2-
PAM should be in such close agreement with those
obtained in the protection experiments with
284051 and eserine. In the case of the inhibitors,
"ageing" could not have influenced the results .
Protection Experiments with the
Specific Inhibitors
284051 is a reversible inhibitor of AChase, while
DFP is irreversible. In these conditions, it is ap-
parent that, with increasing incubation times in a
solution containing both compounds, an increasing
proportion of the AChase will become phosphory-
lated by DFP. The rate of this increase in phos-
phorylation with DFP is dependent on the intrinsic
rate of reaction of DFP with the enzyme, and on
the binding affinity of the inhibitor. In the case of
284C51, Austin and Berry (953) have demon-
strated that this compound is very tightly bound to
AChase, and for rat brain AChase the h value
(concentration for 50% inhibition) is about 10 -e
M under comparable conditions (Fulton and
Mogey, 1954).
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Muscle Sites
No. of molecules
per end plate
Mean X 10
- T
Range
Sternomas- Total DFP-re- 8.8 (6 .2-11 .4)*
toid active sites
AChase$ 3 .1 (2 .2-4.0)
Diaphragm Total DFP-re- 3.0 (2 .5-3 .6)*
active sites
AChase$ 1 .1 (0 .9-1 .2)It has been shown (Barnard and Ostrowski,
1964; Wieckowski and Barnard, in preparation)
that, in the conditions of these experiments, phos-
phorylation by DFP alone is not complete at 16
min, but reaches saturation by 20 min. The ex-
periments involving protection by 284C51 were
carried out with either a 16- or 20-min incubation
in labeled DFP. These times are short for reaction
of the extremely depleted free AChase, and yet
they are only just long enough to enable DFP
to phosphorylate all the available sites in the end-
plate in the absence of competition with 284051 .
When incubation in labeled DFP starts with every
molecule of AChase inhibited by 284C51, and the
incubation medium contains in addition a suitable
concentration of the latter, the probability of
phosphorylation of AChase by DFP in 16-20 min
must be very small.
With eserine, the position is slightly different.
Wilson, Harrison, and Ginsburg (1961), working
with AChase purified from eel electric organ, have
demonstrated that carbamylation, a covalent at-
tachment at the active center, is produced by re-
action with eserine, in addition to the formation of
a noncovalent, reversible complex . Carbamylation
is slowly reversed by hydrolysis, a reactivation with
a half-time of about 40 min at 25 °. Earlier evidence
on mammalian erythrocyte AChase (Goldstein,
1944) is also consistent with such a carbamylation.
After a period of pretreatment with eserine, as we
have used, all the AChase would presumably be in
the carbamyl form, and the chance of phosphoryla-
tion of this enzyme with DFP would be remote .
The Proportion of Phosphorylated Sites
Represented by AChase
It is interesting that the three methods of esti-
mating this contribution of AChase to the total
sites phosphorylated by DFP at the endplate, by
using 2-PAM, 284C51, and eserine, respectively,
each of which has different possible sources of
error, should, nevertheless, give about the same
result. In a similar study on the esterases in mega-
karyocytes of the rat (Darzynkiewicz et al.,
1966 a), excellent agreement has again been ob-
tained between the results of reactivation with
2-PAM and the results of protection with these
same specific inhibitors. Both methods indicated
that approximately 30-35% of the sites of phos-
phorylation by DFP in these cells were AChase .
It seems reasonable to conclude that a proportion
682
	
THE JOURNAL OF CELL BIOLOGY • VOLUME 41, 1969
close to 35% of the DFP-reactive sites measured in
the present work is, in fact, AChase .
The specificity for AChase of the methods used
for this specificity here is based not only upon the
known biochemical evidence obtained on the
enzyme from erythrocytes or brain cited earlier,
but also upon results that have been reported on
rat and mouse motor endplates . The AChase there
has been shown histochemically (and, therefore,
only qualitatively) to be inhibited by 284C51, and
reactivated (after DFP blockade) by 2-PAM
(Koelle, 1963; Denz, 1953 ; Holmstedt, 1957 ;
Pearse, 1961). Quantitative evidence obtained by
Giacobini and Holmstedt (1960) on rat muscle
endplates studied by the micro-diver technique
shows that the activity therein
methacholine specific substrate
284C51 .
One possible
on the AChase-
is abolished by
source of error common to the
three methods used for determining the proportion
of DFP-reactive sites that are AChase is the polar
nature of the agents used for establishing specific-
ity. DFP, which by contrast is lipophilic, might
penetrate to AChase sites within the endplate
which are inaccessible to 2-PAM, 284C51, and
eserine. These experiments were carried out on
fixed material, however, in which permeability
barriers should have been greatly reduced . Two
recent lines of evidence confirm that this type of
error was not present in these experiments. First,
Darzynkiewicz, Wieckowski, and Barnard (un-
published data), by using benzoyl-2-PAM (phenyl-
1-methyl pyridinium-2-ketoxime iodide) have ob-
tained results on mouse diaphragm labeled with
DFP 3H which are identical with the results re-
ported here : this compound of Dr . I. B. Wilson,
benzoyl-2-PAM, has a much higher lipid solubility
than 2-PAM itself. Secondly, in electron micro-
scope radioautographs of sternomastoid endplates
labeled by the two methods "DFP-3H-2-PAM"
and "DFP-2-PAM-DFP-3H," it has recently
been shown by M. M. Salpeter (Salpeter, in
preparation) that the distribution of the sites we
have taken as AChase is identical with the distribu-
tion of the phosphorylated sites resistant to treat-
ment with 2-PAM.
The conclusion that 35% of the sites labeled
represent AChase is not in agreement with brief
reports by Waser and Reller (1965) and Waser
(1967). Working with mouse diaphragm, those
authors claim to abolish phosphorylation with DFP
in motor endplates by pretreatment with Mipafox(N, N-di-isopropylphosphorodiamidic fluoride) .
From their results, they conclude that all the sites
available for phosphorylation must be AChase .
But Mipafox is similar in general structure and in
reactivity to DFP itself, and it is known to inhibit
Chase, for instance, at concentrations lower than
the concentrations at which it inhibits AChase
(Holmstedt, 1957) . Its reactivity with other ester-
ases has not been evaluated biochemically, but is
likely to be considerable. Its value for indicating
the specificity of action of DFP on AChase is,
therefore, considerably less than the value of any of
the agents used in the present work, all of which
are more specific for AChase .
It is interesting that Waser's (1967) value for the
total number of DFP-reactive sites per endplate in
the mouse diaphragm is 2 .5 t 0.5 X 107, a value
very close to the values we report here and have
noted previously (Rogers et al ., 1966), although
Waser has used a radioautographic technique
considerably different from ours.
In earlier grain-counting experiments with
DFP 3H-treated mouse diaphragm, it was also
concluded (Barnard and Ostrowski, 1964) that all
the sites of reaction with DFP in the endplates were
AChase. This view is no longer tenable in view of
the evidence presented in this paper and the suc-
ceeding paper (Rogers and Barnard, 1969) .
The Contribution of Chase and Other Esterases
to the Sites of Phosphorylation by DFP
The proportion of Chase present at the motor
endplate is not very accurately determined in this
material. Ethopropazine has been shown to be
highly specific for Chase at the concentrations
used here (Bayliss and Todrick, 1956 ; Todrick,
1954) . The experiments in which it was used
showed 5% (sternomastoid) and 14% (diaphragm)
protection against phosphorylation by labeled DFP
(Table VI). Eserine, however, which should in-
hibit both AChase and Chase, gave protection
which was quantitatively indistinguishable from
that seen with 284051, suggesting that little, if
any, Chase was present in the endplate .
The presence of Chase at motor endplates has
been demonstrated histochemically (Denz, 1953),
though the techniques used do not permit any firm
statement about the relative amounts of AChase
and Chase.
On the basis of the evidence as a whole, it seems
reasonable to assume that there is relatively little
Chase at the endplates studied. The Chase prob-
ably amounts to less than 10 % of the total number
of sites phosphorylated by DFP.
It is interesting to speculate on the nature of the
other DFP-reactive sites at the motor endplate
which are not AChase or Chase . These other sites
form not less than 55 % of the total sites sensitive to
DFP. The evidence presented here on the persist-
ence of labeling at those sites through an extensive
washing procedure, which includes exchange with
nonradioactive DFP, indicates that phosphoryla-
tion, rather than any noncovalent binding, is
taking place there. It is highly probable that phos-
phorylation of serine residues at the active centers
of hydrolases is involved. There is evidence from
cytochemical color reactions that nonspecific ester-
ases are present at motor endplates (Denz, 1953 ;
Hopsu and Pontinen, 1964), and we have con-
firmed, in the course of these investigations, that
the a-naphthyl acetate reaction for esterases is
given by these endplates and is abolished by prior
treatment with DFP. It is now clear, from the
evidence noted above, that relatively little of this
reactivity to DFP can be attributed to Chase.
These unidentified esterases are present at motor
endplates in higher concentration than AChase
itself, and their nature and role, if any, in neuro-
muscular transmission clearly invite further analy-
sis.
AChase at Endplates of Sternomastoid
and Diaphragm
The values for the numbers of molecules of
AChase at endplates of mouse sternomastoid and
diaphragm are listed in Table VII . The succeeding
paper (Rogers and Barnard, 1969) reports meas-
urements made, by liquid scintillation counting, of
the radioactivity eluted from sternomastoid end-
plates by 2-PAM, after labeling with DFP3H .
The range of values in these experiments was 1 .2-
4.4 X 107 molecules AChase per endplate, with a
mean of 2.4 X 107. This value is in good agreement
with the values reported here.
Electron microscope radioautographs of the
labeled sternomastoid material, obtained by M.
M. Salpeter, have yielded a value of 1 .0-2.0 X 107
molecules AChase per endplate, which is again
within the range of values reported here (Rogers
et al., 1966). It was possible to show (Salpeter,
1967) that over 85 % of the AChase molecules lie in
the region of the junctional folds of the postsynaptic
membrane. It may be presumed that these mole-
cules are associated with the postsynaptic mem-
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683brane itself. On this basis, it has been possible to
calculate from the electron microscope radioauto-
graphic data the density of AChase molecules per
unit area of postsynaptic membrane (Salpeter,
1967) .
DFP-Reactive Sites in Mast Cells
The labeling observed in mast cells is not due to
the presence of AChase . Cholinesterases in mast
cells are not detectable by the usual methods .
Barnard et al. (1968) have shown that, in mast
cells from both rat and mouse, all the sites that
react with DFP are proteases or other esterases : in
the rat, 85 % of the sites are active centers of a
chymotrypsin-like enzyme (Darzynkiewicz and
Barnard, 1967) .
The presence of these cells, which have a con-
centration of DFP-reactive sites far in excess of the
concentration found at endplates, is a potential
source of error in any technique that does not limit
measurement to histologically recognizable end-
plates. It is now apparent that the early work on
DFP3H uptake by mouse diaphragm (Ostrowski
et al., 1963 ; Barnard and Ostrowski, 1964) did not
differentiate mast cells from endplates . Staining of
endplates was avoided in making the radioauto-
graphs in that early work, but, as a consequence,
many of the labeled areas encountered will have
been mast cells and not endplates. Those earlier
results should, therefore, be disregarded in favor of
the results with the present material, in which the
endplates were always clearly demonstrated . In
spite of the difficulties introduced into the measure-
ment of the total number of DFP-reactive sites per
endplate by the prior staining of the tissue by the
Koelle acetylthiocholine method, this or some
similar technique to enable endplates to be posi-
tively identified is essential if acceptable results are
to be obtained with striated muscle . Radioauto-
graphic measurements from relatively wide areas
of tissue, as in the densitometric method of Waser
and Relier (1965), will also inevitably include some
radioactivity from mast cells.
Conclusion on the Technique Employed
It is clear from the results presented here that it
is possible, with relatively simple control experi-
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niques of beta track radioautography .
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